Individual state nursing approvals Colibri Healthcare, LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. In addition to states that accept courses offered by ANCC Accredited Providers, Colibri Healthcare, LLC is an approved Provider of continuing education in nursing by: Alabama Board of Nursing, Provider #ABNP1418 (valid through February 5, 2025); Arkansas State Board of Nursing, Provider #50-4007; California Board of Registered Nursing, Provider #CEP17480 (valid through January 31, 2024); California Board of Vocational Nursing and Psychiatric Technicians (LVN Provider #V15058, PT Provider #V15020; valid through December 31, 2023); District of Columbia Board of
Nursing, Provider #50-4007; Florida Board of Nursing, Provider #50-4007; Georgia Board of Nursing, Provider #50-4007; Kentucky Board of Nursing, Provider #7-0076 (valid through December 31, 2023; CE Broker Provider #50-4007); Michigan Board of Nursing, Provider #50-4007; Mississippi Board of Nursing, Provider #50- 4007; New Mexico Board of Nursing, Provider #50-4007; North Dakota Board of Nursing, Provider #50-4007; South Carolina Board of Nursing, Provider #50-4007; and West Virginia Board of Registered Nurses, Provider #50-4007. This CE program satisfies the Massachusetts States Board’s regulatory requirements as defined in 244 CMR5.00: Continuing Education.
Activity director Deborah Martin, DNP, MBA, RN, NE-BC, FACHE, Director of Learning Innovation Colibri Healthcare, LLC Disclosures Resolution of conflict of interest
Sponsorship/commercial support and non-endorsement It is the policy of Colibri Healthcare, LLC not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
In accordance with the ANCC Standards for Commercial Support for continuing education, Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity. Disclaimer The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative
to diagnostic and treatment options of a specific patient’s medical condition.
©2023: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing, but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers. Course verification All individuals involved have disclosed that they have no No. 241, every reasonable effort has been made to ensure that the content in this course is balanced and unbiased. significant financial or other conflicts of interest pertaining to this course. Likewise, and in compliance with California Assembly Bill
INTRODUCTION
Rashes can be difficult to diagnose, even for the more experienced providers. According to Peck, Roberson, and Feldman (2022), the most common reasons for visits to the dermatologist are skin examination (7.8%), skin lesion (7.5%), and discoloration/abnormal pigmentation (7.3%). For patients younger than age 18 years, the most common reasons for visits are acne (28%), warts (7.7%), and skin rash (6.4%). For patients ages 19–65 years and older than 66 years, skin examinations (7.7%) and skin lesions (10%) were the most common reasons for dermatologist visits, respectively. The difficulty is connecting the patient’s presenting symptoms (e.g., rash) to environmental or internal exposures. Rashes can present for a multitude of reasons, (e.g., viral, allergic, bacterial). Each of these types of eruptions can have its own level of similarity to other rashes and severity of symptoms.
For example, the differential diagnosis for viral exanthem may include chickenpox (varicella-zoster virus); COVID-19 (coronavirus); fifth disease (parvovirus B19); hand, foot, and mouth disease (coxsackievirus A16); measles (morbillivirus); roseola (human herpesvirus 6); rubella (rubella virus); hepatitis (HCV); human immunodeficiency virus (HIV); and mononucleosis (Epstein–Barr virus) to name a few (Cleveland Clinic, 2022). Simple dermatological eruptions can have significantly different prognoses and treatments. Not diagnosing rashes appropriately can be frustrating to the patient and the provider. Assessment and screening are key to ruling out serious conditions disguised as integumentary complaints. The detective work of the NP begins with the chief complaint of “rash.”
Page 34
Book Code: AUS3024
EliteLearning.com/Nursing
Powered by FlippingBook